Hallucinogen abuse with hallucinogen-induced mood disorder
ICD-10 F16.14 is a billable code used to indicate a diagnosis of hallucinogen abuse with hallucinogen-induced mood disorder.
F16.14 refers to a condition characterized by the abuse of hallucinogenic substances, leading to significant mood disturbances. Hallucinogens, such as LSD, psilocybin, and mescaline, can induce profound alterations in perception, mood, and cognitive processes. When individuals abuse these substances, they may experience a range of psychological effects, including euphoria, anxiety, and paranoia. The mood disorder associated with this code can manifest as depressive episodes, manic episodes, or mood swings that are directly linked to hallucinogen use. Diagnosis requires a thorough assessment of the patient's substance use history, mood symptoms, and the temporal relationship between hallucinogen use and mood disturbances. Treatment typically involves a combination of psychotherapy, support groups, and, in some cases, pharmacotherapy to manage mood symptoms. Clinicians must be vigilant in monitoring for potential withdrawal symptoms and the risk of relapse, as hallucinogen abuse can lead to chronic psychological issues and impaired functioning.
Detailed psychiatric evaluations, including substance use history and mood assessments.
Patients presenting with acute mood disturbances following hallucinogen use.
Consideration of co-occurring mental health disorders and the need for integrated treatment plans.
Comprehensive substance use assessments and treatment plans.
Patients in recovery programs experiencing mood swings related to past hallucinogen use.
Focus on relapse prevention strategies and ongoing support.
Used for follow-up visits for patients with hallucinogen-induced mood disorder.
Document the patient's history, mental status examination, and treatment plan.
Psychiatrists should ensure comprehensive assessments are included in the visit notes.
F16.14 includes mood disorders induced by hallucinogen use, while F16.10 refers to hallucinogen abuse without associated mood disorders.
